XML 404 R111.htm IDEA: XBRL DOCUMENT v3.25.0.1
Litigation (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Jul. 31, 2024
Dec. 31, 2024
Dec. 31, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Jul. 02, 2024
Commitments and Contingencies Disclosure [Line Items]              
Other assets   $ 18.9   $ 18.9 $ 194.3    
Securities And Shareholder Litigation              
Commitments and Contingencies Disclosure [Line Items]              
Damages paid   40.0          
Damages paid from insurance proceeds   30.0          
SEC Enforcement Proceeding              
Commitments and Contingencies Disclosure [Line Items]              
Loss contingency accrual, provision       1.5      
Loss contingency, accrual, current   1.5   1.5      
Services              
Commitments and Contingencies Disclosure [Line Items]              
Revenue       103.5 72.8 $ 105.0  
Total Bioservices revenues              
Commitments and Contingencies Disclosure [Line Items]              
Cost of goods and services sold [1]       276.0 $ 189.5 268.5  
Jansen Pharmaceuticals, Inc.              
Commitments and Contingencies Disclosure [Line Items]              
Proceeds from legal settlements $ 50.0     50.0      
Increase in other assets     $ 152.7        
Other assets   $ 0.0   0.0     $ 158.7
Inventory write-offs       110.2      
Jansen Pharmaceuticals, Inc. | Services              
Commitments and Contingencies Disclosure [Line Items]              
Revenue       50.0      
Cost of goods and services sold           $ 12.7  
Jansen Pharmaceuticals, Inc. | Total Bioservices revenues              
Commitments and Contingencies Disclosure [Line Items]              
Cost of goods and services sold       $ 50.0      
[1]
(1) Exclusive of intangible assets amortization